Progress of research into natural products that regulate TGF-β1/Smad pathway for the treatment of hepatic fibrosis
CSTR:
Author:
Affiliation:

1. Guizhou University of Traditional Chinese Medicine, Guizhou 550002, China; 2. the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou 550001, China

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    TGF-β1 is considered a key mediator in the formation of hepatic fibrosis and mainly acts by activating the downstream Smad signaling pathway. Smad2 and Smad3 are two major downstream regulators that promote TGF-β1mediated tissue fibrosis, while Smad7 is a negative-feedback regulator of the TGF-β1/Smad pathway and inhibits TGF-β1mediated hepatic fibrosis. A growing number of studies are showing that natural products can delay the progression of hepatic fibrosis by regulating the TGF-β1/Smad pathway, inhibiting HSC activation, and reducing ECM deposition. This article reviews the molecular mechanism of the TGF-β1/Smad signaling pathway in hepatic fibrosis, and summarizes the natural products that target the regulation of this pathway, providing a reference for research into the treatment of hepatic fibrosis.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 28,2024
  • Revised:
  • Adopted:
  • Online: December 03,2024
  • Published:
Article QR Code